Organotypic models in drug development

This book provides latest findings in organotypic models in drug development and provides the scientific resonance needed in an emerging field of research in disciplines, such as molecular medicine, physiology, and pathophysiology.

Today the research on human-based test systems has gained major interest and funding in the EU and the US has increased over the last years.

Moreover, so-called 3R (reduce, replace, refine animal experiments) centres have been established worldwide.